NSEOutcome of Board Meeting1h ago · 5 Sept 2026, 08:03 pm
Outcome of Board Meeting
Aarey Drugs & Pharmaceuticals Limited · AAREYDRUGS
✦ AI SummaryResults
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026, where the Board of Directors considered and approved the Draft of Board Report and its Annexure and Annual Report along with notice for calling the 36th Annual General Meeting of the Company for the Financial Year 31st March 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026.
Attachments (1)
📄pdf
Download →
AAREYDRUGS_05092026200237_Board_Meeting.pdf
View document text
MANUFACTURER OF
‘(ey
BULK DRUGS &
' IMPORTERS OF
DRUGS & PHARMACEUTICALS LTD. SOLVENTS & CHEMICALS
H.0: 203/4 SAHAKAR BHAVAN, 340/48 N.N STREET, MUMBAI-400009 ® : (022) 23455543 Email: corporate@aareydrugs.com
REGD OFF. & FACTORY: E-34 MIDC, TARAPUR, BOISAR, DIST.-THANE ® (02525) 271049 Email: info@aareydrugs.com
CIN:L99999MHI1990PLC056538
Date: 5™ September, 2026
BSE Limited National Stock Exchange of India Limited
The Manager, Exchange Plaza
Corporate Service Department BandraKurla Complex,
P.J. Towers, Dalal Street, Bandra (E),
Mumbai40-0 001 Mumbai — 400051
Scrip Code: 524412 NSE Symbol: AAREYDRUGS
Sub: Outcome of Board Meeting held on today i.e 5" September, 2026
Dear Sir/Madam,
Pursuant to Regulation 30 (read with Part A of Schedule IIl) of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 ("Listing Regulations"), we wish to inform you that a meeting of the Board of
Directors of the Company was held today, i.e., Saturday, 5™ September, 2026 at 06:00 P.M. at the registered
office of the Company, wherein inter alia, the following matters were considered and approved:
1) The Board of Directors considered and approved the Draft of Board Report and its Annexure and Annual
Report along with notice for calling the 36™ Annual General Meeting of the Company for the Financial Year
31st March 2026.
2) The 36" Annual General Meeting of the Members of the Company will be held on Wednesday, 30" day of
September, 2026 at 3:00 P.M (IST) through Video Conferencing / Other Audio Visual Means (VC/ OAVM).
3) The Board has approved the Book Closure of Register of Members and Transfer Books and Cut-off date for
the purpose of E-voting, for the purpose of 36™ Annual General Meeting.
4) The Board approved the appointment of Scrutinizer Mr. Virendra G. Bhatt as, Practicing Company
Secretaries (COP No.124) for scrutinizing the E- voting to be conducted in the 36" Annual General Meeting of
the Company.
Board meeting commenced at 06:00 P.M and concluded at 7:30 P.M
Kindly take the same on record.
Thanking you,
Yours Faithfully,
For Aarey Drugs & Pharmaceuticals Limited
Nimit R.Ghatalia
Director
DIN: 07069841